Akari Therapeutics Plc (AKTX) stock
AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.65+0.95 (+16.67%)
Close on Nov 18, 2026Market cap $12.95MP/E –Yield –
Akari Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Akari Therapeutics's market cap was $13.04M on Nov 11, 2026, against $15.86M a year earlier. Over the last 5 years it ranged from $5.83M to $70.63M, with a median of $19.99M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.04M | +38.4% |
| 2025 | Dec 31, 2025 | $9.43M | -36.4% |
| 2024 | Dec 31, 2024 | $14.82M | -6.2% |
| 2023 | Dec 29, 2023 | $15.79M | -43.4% |
| 2022 | Dec 30, 2022 | $27.89M | -51.7% |
| 2021 | Dec 31, 2021 | $57.71M | +12.8% |
| 2020 | Dec 31, 2020 | $51.18M | +89.9% |
| 2019 | Dec 31, 2019 | $26.96M | +12.5% |
| 2018 | Dec 31, 2018 | $23.95M | -53.0% |
| 2017 | Dec 29, 2017 | $50.99M | -38.5% |
| 2016 | Dec 30, 2016 | $82.91M | -51.4% |
| 2015 | Dec 31, 2015 | $170.77M | -32.0% |
| 2014 | Dec 31, 2014 | $251.02M | – |
See a number that looks wrong?